Skip to main content
SUNFLOWER PHARMACEUTICAL GROUP CO.,LTD logo

SUNFLOWER PHARMACEUTICAL GROUP CO.,LTD — Investor Relations & Filings

Ticker · 002737 ISIN · CNE100001WT7 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,260 across all filing types
Latest filing 2026-05-08 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002737

About SUNFLOWER PHARMACEUTICAL GROUP CO.,LTD

https://www.kuihuayaoye.com

Sunflower Pharmaceutical Group Co., Ltd. focuses on the research, development, manufacturing, and distribution of proprietary Chinese medicines, chemical drugs, and health supplements. The organization is particularly noted for its specialization in pediatric medicine, marketed under the "Little Sunflower" brand, which includes treatments for respiratory and digestive ailments. Its extensive product portfolio also covers gynecological health and general internal medicine. The group operates several integrated production bases and research institutes, facilitating a comprehensive approach to drug formulation and quality control. By leveraging a robust supply chain and a wide-reaching distribution network, the company provides a diverse range of over-the-counter and prescription solutions aimed at improving family health and wellness.

Recent filings

Filing Released Lang Actions
关于参加黑龙江辖区上市公司2026年投资者网上集体接待日活动的公告
Regulatory Filings
2026-05-08 Chinese
关于独立董事独立性自查情况的专项报告
Governance Information Classification · 82% confidence The document is a special report by the board evaluating the independence of the company’s independent directors, referencing listing rule requirements and self-regulatory guidelines. It is not announcing a board change, vote result, financial results, nor is it a simple report publication notice. Instead, it details the company’s governance practices around director independence, fitting the Governance Information category.
2026-04-26 Chinese
高级管理人员2026年度薪酬方案
Remuneration Information Classification · 95% confidence The document is a detailed annual compensation plan for senior management of 葵花药业集团股份有限公司 for the 2026 fiscal year. It outlines salary structure, performance pay, incentive schemes, payment policies, and related rules. This matches the definition of Remuneration Information (DEF 14A), which covers reports detailing executive/director compensation.
2026-04-26 Chinese
独立董事述职报告-张盈
Governance Information Classification · 85% confidence The document is an independent director’s annual performance report (“独立董事述职报告”), detailing governance activities, committee attendances, and board oversight functions. It is not announcing voting results, director changes, or financial results, but describes corporate governance practices and the director’s duties. This aligns with the Governance Information category.
2026-04-26 Chinese
独立董事述职报告-赵燕
Governance Information Classification · 87% confidence The document is titled “2025年度独立董事述职报告” and is the full performance report of the company’s independent director describing governance activities, meeting attendance, committee work, independence self‐checks, and oversight of internal controls and audits. It is not an earnings release, quarterly or annual financial report, nor an announcement of a board change. Rather, it is a standalone governance report detailing board governance practices and director duties. This matches the Governance Information category (CGR).
2026-04-26 Chinese
关于举行2025年度网上业绩说明会的通知
Regulatory Filings Classification · 60% confidence The document is a notice by 葵花药业集团股份有限公司 to hold its 2025 annual online performance briefing (业绩说明会). It is not the actual annual report, transcript, or presentation itself, nor an earnings release of results. Instead, it is an event invitation/regulatory announcement for an investor relations webcast. There is no dedicated category for IR event invitations, so it falls into the fallback “Regulatory Filings” category (RNS).
2026-04-26 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.